It's crucial to consult with a healthcare provider to discuss the potential benefits and risks of Semaglutide in the context of individual health conditions and medical history
If you develop any type of thyroid tumor, immediately stop taking semaglutide
Several studies have shown that a small percentage of people using GLP-1 receptor agonists experience headaches, but even these results are unclear
"In the STEER study, patients using Wegovy had greater cardiovascular improvements compared to tirzepatide, indicating that the same cardiovascular benefit cannot be generalized across other molecules in the GLP-1 or GIP/GLP-1 classes and may come specifically from the semaglutide molecule," Anna Windle, senior vice president of clinical development and medical and regulatory affairs at Novo Nordisk, said in a release
Our research integrates classical microbiology, whole genome sequencing, metagenomics, emerging molecular detection approaches, and targeted phenotypic analyses